Terlipressin clinical trials
Also written Glypressin.
Includes 1 study of Terlipressin acetate.
How each study uses Terlipressin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Terlipressin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 14 Sept 2022 · TERLIVAZ · NDA 022231 (FDA, Drugs@FDA; as terlipressin acetate)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
64 studies that test it; most in 2022 (7)
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2004 | 3 |
| 2006 | 3 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2012 | 4 |
| 2013 | 4 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 5 |
| 2017 | 2 |
| 2018 | 5 |
| 2019 | 3 |
| 2020 | 5 |
| 2021 | 2 |
| 2022 | 7 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 7 · Other 57
Institute of Liver and Biliary Sciences, India (9) · Wael Elbanna Clinic (4) · Post Graduate Institute of Medical Education and Research, Chandigarh (4) · Assiut University (3) · Mallinckrodt (3) · Hospital Clinic of Barcelona (3) · Aga Khan University (3) · Assistance Publique - Hôpitaux de Paris (2)
Often tested with
Tested in the same studies.
Norepinephrine (5) · Octreotide (3) · Somatostatin (2) · Albumins (2) · Tranexamic Acid (1) · Serelaxin (1) · Arginine Vasopressin (1) · Carbetocin (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2
Studies that test Terlipressin.
- Dec 2026Terlipressin vs Placebo to Reduce Bleeding in Fibroid SurgeryNot applicable · Sevil Cankaya
- Mar 2027Effects of Terlipressin and Somatostatin on Portal Pressure in Patients Undergoing Living Donor Liver TransplantationNot applicable · Istanbul Medipol University Hospital
Studies
Open first, then newest update. How each study uses Terlipressin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 64
- Terlipressin vs Placebo to Reduce Bleeding in Fibroid SurgeryNot yet recruitingNot applicableSevil CankayaNCT07746349Written as terlipressin (vasoconstrictor)How we know
- Effects of Terlipressin and Somatostatin on Portal Pressure in Patients Undergoing Living Donor Liver TransplantationRecruitingNot applicableIstanbul Medipol University HospitalNCT07304466Written as TerlipressinHow we know
- Efficacy and Safety of Continuous Infusion of Terlipressin vs Bolus Terlipressin in ACLF Patients With Acute Esophageal Variceal BleedNot yet recruitingPhase 2/3Institute of Liver and Biliary Sciences, IndiaNCT06815770Written as Terlipressin Injectable ProductHow we know
- Safety and Efficacy of Continuous Infusion of Terlipressin With Norepinephrine Versus Norepinephrine Alone in Improving Outcomes of Acute Kidney Injury in Acute on Chronic Liver Failure With Septic ShockNot yet recruitingNot applicableInstitute of Liver and Biliary Sciences, IndiaNCT06556472Written as TerlipressinHow we know
- The Effect of Intracapsular Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Laparoscopic Myomectomy OperationsRecruitingNot applicableWael Elbanna ClinicNCT05170230Written as TerlipressinHow we know
- The Effect of Intramyometrial Injection of Terlipressin Versus Intramyometrial Injection of Carbitocin on Hemoglobin and Blood Loss During Laparoscopic Myomectomy OperationsRecruitingNot applicableWael Elbanna ClinicNCT05154279Written as TerlipressinHow we know
- Continuous Versus Bolus Infusion of Terlipressin for Portal Hypertension Related Bleeding in Liver CirrhosisNot yet recruitingNot applicableGeneral Hospital of Shenyang Military RegionNCT03130127Written as TerlipressinHow we know
- Study to Evaluate R2R01 Plus Terlipressin Versus Terlipressin Alone in Patients With Hepatorenal SyndromeRecruitingPhase 2River 2 Renal Corp.NCT05875948Written as TerlipressinHow we know
- Efficacy of Continuous Terlipressin Therapy After Endoscopic Variceal LigationNot yet recruitingPhase 3Post Graduate Institute of Medical Education and Research, ChandigarhNCT06027970Written as TerlipressinHow we know
- The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myomectomy Operations Without Using Haemostatic TourniquetsRecruitingNot applicableWael Elbanna ClinicNCT05266534Written as TerlipressinHow we know
- Terlipressin for Refractory Septic ShockRecruitingPhase 2Mahidol UniversityNCT04339868Written as TerlipressinHow we know
- Effect of Terlipressin on the Incidence of Early Postoperative Acute Kidney Injury in Liver Transplantation PatientsCompletedPhase 4Beijing Tsinghua Chang Gung HospitalNCT06108362Written as TerlipressinHow we know
- Effect of Terlipressin for Intraoperative Blood Pressure Management in Kidney TransplantationActive, not recruitingNot applicableBeijing Friendship HospitalNCT06855758Written as terlipressinHow we know
- ACid Tranexamic or Terlipressin for Initial Emergency Treatment of Mild to seVere hEmoptysis: a Randomized Trial.CompletedPhase 3Assistance Publique - Hôpitaux de ParisNCT04961528Written as TerlipressinHow we know
- Comparison of Terlipressin Versus Octreotide in Patients With Hepatorenal SyndromeCompletedNot applicableLahore General HospitalNCT07460908Written as terlipressinHow we know
- Terlipressin for HRS-AKI in Liver Transplant Candidates (INFUSE)CompletedPhase 3University of PennsylvaniaNCT04460560Written as TerlipressinHow we know
- The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myomectomy Operations Using Haemostatic Tourniquets:CompletedNot applicableWael Elbanna ClinicNCT05242783Written as TerlipressinHow we know
- Noradrenaline Versus Glypressin for Prevention of Hypotension After Deflation of Tourniquet in Knee ArthroplastyCompletedNot applicableTanta UniversityNCT05774067Written as glypressinHow we know
- Terlipressin Infusion During Whipple Procedure: Effect on Blood Loss and Transfusion NeedsCompletedPhase 2Assiut UniversityNCT03572088Written as TerlipressinHow we know
- Terlipressin Infusion Alone Vs Terlipressin With Noradrenaline Infusion In The Treatment of Hepatorenal Syndrome Type 1CompletedPhase 3Post Graduate Institute of Medical Education and Research, ChandigarhNCT03822091Written as TerlipressinHow we know
See all 64 studies that test Terlipressin →
Given beside what is tested · 2 — Terlipressin is usual care or a partner of the new treatment
- Decision Support for Intraoperative Low Blood PressureCompletedNot applicableVanderbilt University Medical CenterNCT02726620Written as TerlipressinHow we know
- To Assess the Efficacy of Early Introduction of a Combination of Low Dose Vasopressin Analogue in Addition to Noradrenaline as a Vasopressor in Patients of Cirrhosis With Septic ShockCompletedNot applicableInstitute of Liver and Biliary Sciences, IndiaNCT02468063Written as Low dose terlipressinHow we know
As the comparator · 4 — what is tested is compared with Terlipressin
- Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal SyndromeActive, not recruitingPhase 2Noorik Biopharmaceuticals AGNCT06256432Written as TerlipressinHow we know
- To Compare the Response Rate of Noradrenaline vs. Terlipressin in Hepatorenal Syndrome in Patients With Acute on Chronic Liver FailureCompletedNot applicableInstitute of Liver and Biliary Sciences, IndiaNCT02573727Written as Terlipressin + albuminHow we know
- Terlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal SyndromeTerminatedPhase 2/3University of PadovaNCT00742339Written as Terlipressin plus albuminHow we know
- Noradrenalin vs Terlipressin in Hepatorenal SyndromeCompletedPhase 3University of Turin, ItalyNCT00370253Written as TerlipressinHow we know
Codes
What other systems call Terlipressin · ClinicalTrials.gg INT006762
- MeSH (NLM) D000077585TerlipressinConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 7Z5X49W53PTERLIPRESSINConfirmed FDA, NLM
- RxNorm 57048One source FDA
- NCI Thesaurus C77387TerlipressinOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077585 | Terlipressin | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 7Z5X49W53P | TERLIPRESSIN | Confirmed FDA, NLM |
| RxNorm | 57048 | — | One source FDA |
| NCI Thesaurus | C77387 | Terlipressin | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.